Issues

Vol. 4 (No. 2-Special) 2022 May

The value of the partnership between the pharmaceutical industry and SIF for innovation and sustainability

The document was edited by the Editorial Committee consisting of: Carlo Piccinni (coordinator)¹, Danilo Norata², Cristiano Chiamulera³, Laura Franzini⁴

Preface, 4-75

doi: none

Full text PDF
Facing changes in the pharmacological research and in the pharmaceutical industry

G. Racagni^1,2, N. Martini³, M. Zibellini⁴

Introduction, 5-8

doi: n/a

Full text PDF
Working agenda and map for the future

L. Bergamini, L. Berrino, A. Capuano, C. Chiamulera, G. Cirino, R. Danesi, A. De Luca, L. Franzini, M. Mangrella, N. Martini, G. Minotti, G. D. Norata, G. Panina, C. Piccinni, A. M. Porrini, G. Racagni, G. Sava, M. Scatigna, M. Simonato, G. Trifirò, D. Valle, M. Zibellini.

Opinion Papers, 9-75

doi: 10.36118/pharmadvances.2022.35

Full text PDF

Download entire Vol. 4 (No. 2-Special) 2022 May